News & Updates

Watermelon good for the heart

Eating watermelon appears to have cardiovascular benefits, with the results of a systematic review and meta-analysis showing that the fruit has potential antihypertensive effects.

Swarming microrobotic platform enables aneurysm embolization with high fifilling ratio

Dapagliflozin helps prevent heart failure events, cardiovascular death

Treatment with dapagliflozin leads to a reduction in the rate of total heart failure (HF) events and cardiovascular death, irrespective of patient characteristics such as ejection fraction (EF), according to data from the DELIVER* trial.

Early hysterectomy poses increased CVD risk

Undergoing early hysterectomy appears to put women at heightened risk of a composite of cardiovascular disease (CVD), especially stroke, as reported in a study.

Atrial fibrillation patients use same anticoagulant after bleeding event

A recent study has shown that the majority of patients with nonvalvular atrial fibrillation who have had a bleeding event resume anticoagulation therapy usually with the same drug class that they have been using.

Thiazide plus potassium-sparing diuretics outdoes monotherapy in hypertension

Use of thiazides with potassium-sparing (PS) diuretics results in greater blood pressure (BP)-lowering efficacy, as well as reduces hypokalaemia and hyperglycaemia, compared with thiazides alone, reports a recent study.

Sacubitril/valsartan outdoes valsartan on ventricular remodeling in perimenopausal hypertension

Treatment with sacubitril/valsartan appears to be better than valsartan alone in reversing ventricular remodeling in perimenopausal hypertensive women, suggests a study.